Literature DB >> 28393035

Retinal ganglion cell complex changes using spectral domain optical coherence tomography in diabetic patients without retinopathy.

Ahmed I Hegazy1, Rasha H Zedan1, Tamer A Macky1, Soheir M Esmat1.   

Abstract

AIM: To assess the ganglion cell complex (GCC) thickness in diabetic eyes without retinopathy.
METHODS: Two groups included 45 diabetic eyes without retinopathy and 21 non diabetic eyes. All subjects underwent full medical and ophthalmological history, full ophthalmological examination, measuring GCC thickness and central foveal thickness (CFT) using the RTVue® spectral domain-optical coherence tomography (SD-OCT), and HbA1C level.
RESULTS: GCC focal loss volume (FLV%) was significantly more in diabetic eyes (22.2% below normal) than normal eyes (P=0.024). No statistically significant difference was found between the diabetic group and the control group regarding GCC global loss volume (GLV%) (P=0.160). CFT was positively correlated to the average, superior and inferior GCC (P=0.001, 0.000 and 0.001 respectively) and negatively correlated to GLV% and FLV% (P=0.002 and 0.031 respectively) in diabetic eyes. C/D ratio in diabetic eyes was negatively correlated to average, superior and inferior GCC (P=0.015, 0.007 and 0.017 respectively). The FLV% was negatively correlated to the refraction and level of HbA1c (P=0.019 and 0.013 respectively) and positively correlated to the best corrected visual acuity (BCVA) in logMAR in diabetic group (P=0.004).
CONCLUSION: Significant GCC thinning in diabetes predates retinal vasculopathy, which is mainly focal rather than diffuse. It has no preference to either the superior or inferior halves of the macula. Increase of myopic error is significantly accompanied with increased focal GCC loss. GCC loss is accompanied with increased C/D ratio in diabetic eyes.

Entities:  

Keywords:  diabetes; ganglion cell complex; optical coherence tomography; retina

Year:  2017        PMID: 28393035      PMCID: PMC5360779          DOI: 10.18240/ijo.2017.03.16

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

1.  Early neurodegeneration in the retina of type 2 diabetic patients.

Authors:  Hille W van Dijk; Frank D Verbraak; Pauline H B Kok; Marilette Stehouwer; Mona K Garvin; Milan Sonka; J Hans DeVries; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

2.  Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats.

Authors:  Yoshinori Aizu; Kiyomitsu Oyanagi; Jianguo Hu; Hachiro Nakagawa
Journal:  Neuropathology       Date:  2002-09       Impact factor: 1.906

3.  Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy?

Authors:  Aditya Verma; Rajiv Raman; K Vaitheeswaran; Swakshyar Saumya Pal; Gella Laxmi; Muneeswar Gupta; S Chandra Shekar; Tarun Sharma
Journal:  Ophthalmic Res       Date:  2011-12-16       Impact factor: 2.892

4.  Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy.

Authors:  TiePei Zhu; Jin Ma; YongHao Li; Zheng Zhang
Journal:  Sci China Life Sci       Date:  2015-05-08       Impact factor: 6.038

5.  Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

Authors:  Hille W van Dijk; Frank D Verbraak; Pauline H B Kok; Mona K Garvin; Milan Sonka; Kyungmoo Lee; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-03       Impact factor: 4.799

Review 6.  Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

Authors:  Erica L Fletcher; Joanna A Phipps; Michelle M Ward; Theresa Puthussery; Jennifer L Wilkinson-Berka
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

7.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

8.  Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy.

Authors:  E Chihara; T Matsuoka; Y Ogura; M Matsumura
Journal:  Ophthalmology       Date:  1993-08       Impact factor: 12.079

9.  Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography.

Authors:  Ou Tan; Vikas Chopra; Ake Tzu-Hui Lu; Joel S Schuman; Hiroshi Ishikawa; Gadi Wollstein; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2009-09-10       Impact factor: 12.079

10.  Retinal nerve fiber layer and ganglion cell complex thickness in patients with type 2 diabetes mellitus.

Authors:  Mehmet Demir; Ersin Oba; Hakan Sensoz; Erhan Ozdal
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

View more
  8 in total

1.  Optical coherence tomography indices for diagnosis of chronic glaucoma in patients with diabetes mellitus: a pilot study.

Authors:  Fatma K Hassan; Karim Adly Raafat; Khaled E Elrakhawy; Riham S H M Allam
Journal:  Int Ophthalmol       Date:  2020-09-18       Impact factor: 2.031

2.  Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats.

Authors:  Rozina I Hajdú; Lenke K Laurik; Klaudia Szabó; Bulcsú Dékány; Zsuzsanna Almási; Anna Énzsöly; Arnold Szabó; Tamás Radovits; Csaba Mátyás; Attila Oláh; Ágoston Szél; Gábor M Somfai; Csaba Dávid; Ákos Lukáts
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

3.  Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor.

Authors:  Donald R Nixon; Nicholas Flinn
Journal:  Clin Ophthalmol       Date:  2021-04-20

4.  Relationship between diabetic retinopathy and diabetic peripheral neuropathy - Neurodegenerative and microvascular changes.

Authors:  Rehna Rasheed; Gopal S Pillai; Harish Kumar; Adish Thayyil Shajan; Natasha Radhakrishnan; Greeshma C Ravindran
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept.

Authors:  Donald R Nixon; Nicholas Flinn; Claudia Enderlein
Journal:  Clin Ophthalmol       Date:  2021-11-11

6.  Retinal Microvascular and Neuronal Changes Are Also Present, Even If Differently, in Adolescents with Type 1 Diabetes without Clinical Diabetic Retinopathy.

Authors:  Elisabetta Pilotto; Tommaso Torresin; Francesca Leonardi; Joaquin Gutierrez De Rubalcava Doblas; Giulia Midena; Carlo Moretti; Edoardo Midena
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

7.  Macular Inner Retinal Layer Thinning in Diabetic Patients without Retinopathy Measured by Spectral Domain Optical Coherence Tomography.

Authors:  Mário Pincelli Netto; Verônica Castro Lima; Maria Angélica Pacheco; Nichard Unonius; Carolina Pb Gracitelli; Tiago Santos Prata
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

8.  Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy.

Authors:  Xiuhua Jia; Zhijian Zhong; Tiancheng Bao; Shasha Wang; Ting Jiang; Yanling Zhang; Qigen Li; Xiang Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.